Trump Announces Cost Cuts to Weight Loss Drugs

Published 3 hours ago·Updated 2 hours ago

story

Above: Donald Trump with the CEOs of Eli Lilly and Novo Nordisk at the White House in Washington, D.C., on Nov. 6, 2025. Image copyright: Aaron Schwartz/Bloomberg/Getty Images

The Spin

Republican narrative

This deal is the latest step in President Trump’s mission to make life affordable for every American. By forcing Big Pharma to match the world's lowest prices and expanding Medicare access, Trump is delivering real savings for families battling diabetes, heart disease and obesity. He and RFK Jr. are making America healthy again by putting health and affordability first.

Trump White House on X

Democratic narrative

Trump's latest "Make America Healthy Again" deal is more hype than help. Experts warn TrumpRx is a risky data grab, not a real fix. What's worse, while drug prices may drop on paper, most Americans, who are covered by other insurance, won't see savings. Meanwhile, cuts to public health funding and leadership chaos show MAHA is failing to truly protect Americans' health.

The New Republic NPR

Cynical narrative

What’s being promoted as a miraculous fix to obesity may simply be a perpetual revenue stream. These drugs mask underlying habits instead of addressing them, and the long-term safety, withdrawal risks and metabolic consequences remain unclear — turning weight management into chronic pharmaceutical dependency rather than lasting lifestyle change.

Abel James on Substack